A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma

Immunogenetics

Volumn 44, Issue 5, 1996, Pages 323-330

  Gaugler, Béatrice ^a,b   Brouwenstijn, Nathalie ^c   Vantomme, Valérie ^a,b   Szikora, Jean Pierre ^a,b   Van Der Spek, Corry W ^c   Patard, Jean Jacques ^a,b   Boon, Thierry ^a,b   Schrier, Peter ^c   Van Den Eynde, Benoît J ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B7 ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; BLADDER CARCINOMA; CARCINOMA CELL; CELL LINE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MELANOMA CELL; PRIORITY JOURNAL;

EID: 0029818386     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02602776     Document Type: Article

References (42)

1. Abi-Hanna, D., Wakefield, D., and Watkins, S. HLA antigens in ocular tissues. I. In vivo expression in human eyes. Transplantation 45: 610-613, 1988
2. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179: 1005-1009, 1994
3. Balch, C. M., Riley, L. B., Bae, Y. J., Salmeron, M. A., Platsoucas, C. D., von Eschenbach, A., and Itoh, K.: Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 125: 200-205, 1990
4. Barker, C. F. and Billingham, R. E. Immunologically privileged sites. Adv Immunol 25: 1-54, 1977
5. Belldegrun, A., Muul, L. M., and Rosenberg, S. A. Interleukin-2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res 48: 206-214, 1988
6. Belldegrun, A., Pierce, W., Kaboo, R., Tso, C.-L., Shau, H., Turcillo, P., Moldawer, N., Golub, S., deKernion, J., and Figlin, R. Interferon-α primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-α as therapy for metastatic renal cell carcinoma. J Urol 150: 1384-1390, 1993
7. Boël, P., Wildmann, C., Sensi, M.-L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T., and van der Bruggen, P. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2: 167-175, 1995
8. Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12: 337-365, 1994
9. Boon, T., Van Snick, J., Van Pel, A., Uyttenhove, C., and Marchand, M. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J Exp Med 152: 1184-1193, 1980
10. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178: 489-495, 1993
11. Brouwenstijn, N., Gaugler, B., Krüse, K. M., Van der Spek, C. W., Mulder, A., Osanto, S., Van den Eynde, B. J., and Schrier, P. I. Renal cell carcinoma-specific lysis by CTL clones isolated from peripheral blood lymphocytes and tumor infiltrating lymphocytes. Int J Cancer, in press
12. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. Induction of antitumor cytotoxic T lymphocytes in normal human using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 91: 2105-2109, 1994
13. Chomez, P., Williams, R., De Backer, O., Boon, T. and Vennström, B. The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation. Immunogenetics 43: 97-100, 1995
14. Coulie, P. G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J.-P., Renauld, J.-C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180: 35-42, 1994
15. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 92: 7976-7980, 1995
16. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L., Jr. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264: 716-719, 1994
17. Davis, L. G., Dibner, M. D., and Battey, J. F. Guanidine isothiocyanate preparation of RNA. In L. G. Davis, M. D. Dibner, and J. F. Battey (eds): Basic Methods in Molecular Biology, pp. 130-135, Elsevier Science Publishing New York, 1986
18. Ennis, P. D., Zemmour, J., Salter, R. D., and Parham, P. Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc Natl Acad Sci USA 87: 2833-2837, 1990
19. Frohman, M. A., Dush, M. K., and Martin, G. R. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 85: 8998-9002, 1988
20. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179: 921-930, 1994
21. Hérin, M., Lemoine, C., Weynants, P., Vessière F., Van Pel, A., Knuth, A., Devos, R., and Boon, T. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 39: 390-396, 1987
22. Hirose, Y., Takamatsu, M., and Harada, F. Presence of env genes in members of the RTVL-H family of human endogenous retrovirus-like elements. Virology 192: 52-61, 1993
23. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91: 6458-6462, 1994
24. Kozak, M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115: 887-903, 1991
25. 5 gene. Biochem Biophys Res Commun 209: 894-900, 1995
26. Mager, D. L. and Freeman, J. D. Human endogenous retroviruslike genome with type C pol sequences and if gag sequences related to human T-cell lymphotropic viruses. J Virol 61: 4060-4066, 1987
27. Marchand, M., Weynants, P., Rankin, K., Arienti, E., Belli, F., Parmiani, G, Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J.-L., Laurent, C., Nueyaert, J.-M., Plagne, R., Deraemaeker, R., Knuth, A., Jäger, E., Brasseur, F., Herman, J., Coulie, P. G., and Boon, T. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 63: 883-885, 1995
28. Mizushima, S. and Nagata, S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18: 5322, 1990
29. Oliver, R. T. D., Nethersell, A. B. W., and Bottomley, J. M. Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma. Br J Urol 63: 128-131, 1989
30. Palmer, P. A., Vinke, J., Evers, P., Pourreau, C., Oskam, R., Roest, G., Vlems, F., Becker, L., Loriaux, E., and Franks, C. R. Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma. Eur J Cancer 28A: 1038-1044, 1992
31. Rosenberg, S. A. The immunotherapy and gene therapy of cancer. J Clin Oncol 10: 180-199, 1992
32. Rosenberg, S. A., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Weber, J. S., Parkinson, D. R., Seipp, C. A., Einhorn, J. H., and White, D. E. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271: 907-913, 1994
33. Seed, B. and Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 84: 3365-3369, 1987
34. Streilein, J. W. Unraveling immune privilege. Science 270: 1158-1159, 1995
35. Takahashi, K., Shichijo, S., Noguchi, M., Hirohata, M., and Itoh, K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 55: 3478-3482, 1995
36. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35: 145-152, 1992
37. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182: 689-698, 1995
38. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 24: 3038-3043, 1994
39. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991
40. Wang, R.-F., Robbins, P. F., Kawakami, Y., Kang, X.-Q., and Rosenberg, S. A. Identification of a gene encoding a melanoma tumor antigen recognized by HEA-A31-restricted tumor-infiltrating lymphocytes. J Exp Med 181: 799-804, 1995
41. Weiss, G. R., Margolin, K. A., Aronson, F. R. Sznol, M., Atkins, M. B., Dutcher, J. P., Gaynor, E. R., Boldt, D. H., Doroshow, J. H., Bar, M. H., Hawkins, M. J., Demchak, P. A., Gucalp, R., and Fisher, R. I. A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. J Clin Oncol 10: 275-281, 1992
42. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269: 1281-1284, 1995